HBM Healthcare Investments AG Share Price Swiss Exchange

Equities

HBMNE

CH0257717097

Investment Management & Fund Operators

Delayed Swiss Exchange 10:06:22 17/06/2024 BST 5-day change 1st Jan Change
210.5 CHF 0.00% Intraday chart for HBM Healthcare Investments AG +0.24% +15.79%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2025 * 76.9M 86.18M 6.81B Sales 2026 * 132M 148M 11.71B Capitalization 1.42B 1.59B 126B
Net income 2025 * 51M 57.15M 4.51B Net income 2026 * 107M 120M 9.47B EV / Sales 2025 * 16.9 x
Net cash position 2025 * 117M 131M 10.36B Net cash position 2026 * 126M 141M 11.15B EV / Sales 2026 * 9.77 x
P/E ratio 2025 *
28.5 x
P/E ratio 2026 *
13.5 x
Employees 700
Yield 2025 *
3.48%
Yield 2026 *
3.84%
Free-Float 81.48%
More Fundamentals * Assessed data
Dynamic Chart
1 week+0.24%
Current month+0.72%
1 month+4.21%
3 months+10.44%
6 months+20.29%
Current year+15.79%
More quotes
1 week
206.00
Extreme 206
213.00
1 month
198.00
Extreme 198
213.00
Current year
156.40
Extreme 156.4
213.00
1 year
148.20
Extreme 148.2
256.50
3 years
148.20
Extreme 148.2
256.50
5 years
140.80
Extreme 140.8
256.50
10 years
89.80
Extreme 89.8
256.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 30/06/01
Director of Finance/CFO 54 31/10/11
Corporate Secretary 60 -
Members of the board TitleAgeSince
Chairman 68 31/05/09
Director/Board Member 69 17/06/21
Director/Board Member 52 31/12/11
More insiders
Date Price Change Volume
17/06/24 210.5 0.00% 150
14/06/24 210.5 -0.47% 600
13/06/24 211.5 +0.24% 600
12/06/24 211 -0.24% 600
11/06/24 211.5 +0.71% 600

Delayed Quote Swiss Exchange, June 17, 2024 at 10:06 am

More quotes
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
206.5 CHF
Average target price
236 CHF
Spread / Average Target
+14.29%
Consensus

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW